Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granulocyte Transfusions After Umbilical Cord Blood Transplant for Leukaemia
NCT05425043Active, not recruiting
- Sponsor
- The University of Manchester
- Start
- Sep 2021
- Primary completion
- Jun 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of granulocytes in acute leukemia (2 arms), sponsored by The University of Manchester. Primary endpoints: Cytokine Release Syndrome at 2 years and Allo-immunisation at 2 years. Started Sep 2021; status: active, not recruiting.
02
Drugs
granulocytes
03
Conditions
acute leukemia
Beyond the preview
Go deeper on NCT05425043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05425043.